About
Armand Cognetta completed a PhD in chemical biology at Scripps Research Institute under Benjamin F. Cravatt, where he co-authored research in peer-reviewed journals and contributed to patent portfolios for two acquired therapeutics companies. He was an early employee at Inzen Tx before founding General Proximity.
Armand @armandcognetta
working on it https://t.co/aWtfw1TR1y
Jul 16, 2026 Β· β₯ 7
Armand @armandcognetta
π https://t.co/vpgh0QbjlV
Jul 15, 2026 Β· β₯ 9
Armand @armandcognetta
completely agree. biotech has been harder to disrupt than tech for various structural reasons, and that's allowed many bloated, bureaucratic, slow, and overly conservative companies to survive the market is coming for them though, and patients will benefit from this https://t.co/QDvD9b5WDj
Jun 22, 2026 Β· β₯ 4
Founder at General ProximityYC W20
Intro paths
Armand went through Y Combinator (Winter 2020) β any YC alum in your network can reach them through the YC community.
Their group partner at YC was Jared Friedman, General Partner at Y Combinator β the partner who ran General Proximity's batch and knows the company first-hand. YC profile β
In turn, Armand can intro founders to General Proximity's investors below.